CareLit Fachartikel

The Use of Bioactive Glass S53P4 as Bone Graft Substitute in the Treatment of Chronic Osteomyelitis and Infected Non-Unions – a Retrospective Study of 50 Patients

Malat, T.-A.; Glombitza, M.; Dahmen, J.; Hax, P.-M.; Steinhausen, E. · NeuroTransmitter · 2018 · Heft 02 · S. 152 bis 159

Dokument
639777
CareLit-ID
Jahr
2018
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
NeuroTransmitter
Autor:innen
Malat, T.-A.; Glombitza, M.; Dahmen, J.; Hax, P.-M.; Steinhausen, E.
Ausgabe
Heft 02 / 2018
Jahrgang 156
Seiten
152 bis 159
Erschienen: 2018-04-01 00:00:00
ISSN
1864-6697;1864-6743

Zusammenfassung

Abstract Background Treatment of chronic osteomyelitis (COM) remains challenging and often results in large bone defects. Dead space management and proper defect filling are essential for successful treatment. Bioactive glass S53P4 (BAG-S53P4) is an anorganic bone graft substitute with antibacterial, osteoconductive, osteostimulative and angiogenic properties. The aim of our study was to analyse the outcome of patients with COM and infected non-unions, whose bone defects were filled with BAG-S53P4. Material and Methods In this retrospective study (07/13 – 02/16), we analysed all patients with COM and infected no…

Schlagworte

After NeuroTransmitter